Artificial Intelligence Program Predicts Dystonia Patients’ Response to Botox with Nearly 100% Accuracy
Neurology Today | February 2, 2023
An artificial intelligence program called DystoniaBoTXNet identified regions of the brain that served as a biomarker of treatment efficacy and distinguished which patients would benefit from botulinum toxin injections.